This was the stock's fourth consecutive day of gains.

Here is how Adaptive Biotechnologies (ADPT) and CVS Health (CVS) have performed compared to their sector so far this year.

KMG Fiduciary Partners LLC dramatically reduced its investment in CVS Health, selling off 88.1% of its shares. The investor ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...

With a market cap of $80.4 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company headquartered in ...

Wall Street gains as S&P 500 surpasses 6,000; key healthcare stock movers revealed. Explore top deals, trends, and regulatory updates in the sector.

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $84.00. The company’s shares closed yester ...

We recently published a list of Jim Cramer Discusses Melting Trade Tensions & These 12 Stocks. In this article, we are going ...

Cantor Fitzgerald analyst Sarah James reiterated a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $71.00. The company’s shares opened today a ...

CVS Health’s stock has been trending on investor radar, but not for all the right reasons—its recent 4% dip contrasts the S&P ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Ratings for CVS Health CVS were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish ...